'We will combat COVID-19 with faster speed, coordination,' says Narendra Modi after review meeting

On Saturday, Modi reviewed the availability and supply of ventilators, oxygen, and medicines and called for utilising the 'entire national capacity' to produce vaccines

Press Trust of India April 18, 2021 13:36:28 IST
'We will combat COVID-19 with faster speed, coordination,' says Narendra Modi after review meeting

File photo of Prime Minister Narendra Modi. ANI

New Delhi: As the daily COVID-19 cases surged to a staggering record-high level, Prime Minister Narendra Modi on Saturday reviewed the availability and supply of ventilators, oxygen and medicines to fight this pandemic and called for utilising the entire national capacity across private and public sectors to produce vaccines, amid concerns in various states about lack of these essentials.

Chairing a meeting to review the status of preparedness to handle the COVID-19 situation, Modi said local administrations needed to be proactive and sensitive to people's concerns.

Follow LIVE updates on COVID-19 here

Modi said there is no substitute for 'testing, tracking and treatment', and that early testing and proper tracking remain key to reducing mortality.

"Together India had defeated COVID-19 last year and India can do it again, with the same principles but faster speed and coordination," he said.

Directing officials to ensure close coordination with states, he said all necessary measures must be taken to ramp up the availability of hospital beds for COVID patients and that additional supply of beds through temporary hospitals and isolation centres should be ensured.

He also spoke about a need to utilise the full potential of India's pharmaceutical industry to meet the rising demand of various medicines and reviewed the status of the supply of Remdesivir and other medicines.

On the issue of vaccination, the prime minister directed all officials to make efforts to utilize the entire national capacity, in the public as well as the private sector, to ramp up vaccine production.

Later in a tweet, Modi said, "Reviewed preparedness to handle the ongoing COVID-19 situation. Aspects relating to medicines, oxygen, ventilators and vaccination were discussed. Like we did last year, we will successfully fight COVID with even greater speed and coordination."

The meeting came in the midst of a huge surge in COVID-19 cases across the country with reports pouring in from many states about the shortage of hospital facilities and essentials like oxygen supply.

The prime minister has been holding meetings with chief ministers and officials on a regular basis to discuss the situation and take measures to curb the pandemic.

A record single-day rise of 2,34,692 cases and 1,341 fatalities have pushed India's COVID-19 tally to 1,45,26,609 and the death toll due to the viral disease to 1,75,649, the health ministry said earlier on Saturday.

The number of active coronavirus cases in the country has also surpassed the 16-lakh mark, the ministry's data updated at 8 am showed.

Registering a steady increase for the 38th day in a row, the tally of active COVID-19 cases has climbed to 16,79,740 in the country, accounting for 11.56 percent of its total caseload, while the national COVID-19 recovery rate has dropped to 87.23 per cent.

In the meeting, Modi was joined by Cabinet Secretary, Principal Secretary to PM, Union Home Secretary, Union Health Secretary and the Pharmaceutical Secretary, among others while Dr VK Paul, Member, Niti Aayog, was also present.

An official statement said Modi was briefed on actions taken to address the issue of the availability of Remdesivir.

"Through the efforts of the government, capacity and production augmentation for manufacturing of Remdesivir has been ramped up to provide around 74.10 lakh vials/month in May while the normal production output in January-February being just 27-29 lakh vials/month," it noted.

Supplies have also increased from 67,900 vials on 11th April going up to over 2,06,000 vials on 15th April 2021 which are being particularly focused on states with high caseload and high demand, it added.

Modi took note of the ramped-up production capacity and directed that issues relating to real-time supply chain management to states.

The prime minister directed that the use of Remdesivir and other medicines must be in accordance with approved medical guidelines and that their misuse and black marketing must be strictly curbed.

On the issue of the supply of medical oxygen, Modi directed that the installation of approved medical oxygen plants should be sped up.

According to the statement, 162 PSA oxygen plants are being installed in 32 states and UTs from the PM CARES fund. Modi was informed that one lakh cylinders are being procured and will be supplied to states soon.

The statement said officials told Modi that they are in constant touch with 12 high burden states in assessing the current and future requirement of medical oxygen.

A supply mapping plan for 12 high burden states till April 30 has also been undertaken. Modi also said that the supply of oxygen required for the production of medicines and equipment necessary to handle the pandemic should also be ensured.

Reviewing the status of availability and supply of ventilators, Modi noted that a real-time monitoring system has been created, and directed that state government concerned should be sensitized to use the system pro-actively.

Updated Date:

also read

COVID-19 vaccine supply crisis: Centre should amend Income Tax Act, invoke Companies Act, 2013 for manufacturers
India

COVID-19 vaccine supply crisis: Centre should amend Income Tax Act, invoke Companies Act, 2013 for manufacturers

Government needs to do is to call the bluff on "profits" and so called "super profits" which are allegedly required to re-investment and R&D to produce more vaccines. An urgent amendment to the Income Tax Act, 1961 is needed.

COVID-19 vaccine: US to send 'urgently required' raw material to manufacture Covishield in India
India

COVID-19 vaccine: US to send 'urgently required' raw material to manufacture Covishield in India

The Biden administration had earlier come under criticism from several quarters for not releasing surplus COVID-19 vaccines to India, which is experiencing its worst-ever public health crisis

COVID is a 'mild disease', less than 5% of patients need ventilator, says AIIMS chief Randeep Guleria
India

COVID is a 'mild disease', less than 5% of patients need ventilator, says AIIMS chief Randeep Guleria

Speaking at a press conference in Delhi, the AIIMS director, appealing to the public not to hoard Remdesevir or oxygen cylinders at home, said 85 to 90 percent of people get only mild coronavirus infections